BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yao W, Wang X, Xiao K. Protective effect of berberine against cardiac ischemia/reperfusion injury by inhibiting apoptosis through the activation of Smad7. Mol Cell Probes 2018;38:38-44. [PMID: 29278748 DOI: 10.1016/j.mcp.2017.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, Barrea L, Hassan STS, Šmejkal K, Malaník M, Sychrová A, Barreca D, Ziberna L, Mahomoodally MF, Zengin G, Xu S, Nabavi SM, Shen AZ. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics 2019;9:1923-51. [PMID: 31037148 DOI: 10.7150/thno.30787] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 26.7] [Reference Citation Analysis]
2 Liu DQ, Chen SP, Sun J, Wang XM, Chen N, Zhou YQ, Tian YK, Ye DW. Berberine protects against ischemia-reperfusion injury: A review of evidence from animal models and clinical studies. Pharmacol Res 2019;148:104385. [PMID: 31400402 DOI: 10.1016/j.phrs.2019.104385] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
3 Fu Y, Tang Y, Wang J, Guo Z. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway. Med Sci Monit 2019;25:4801-10. [PMID: 31251735 DOI: 10.12659/MSM.916939] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
4 Li X, Zeng X. Shikonin suppresses progression and epithelial-mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR-106b/SMAD7/TGF-β signaling pathway. Cell Biol Int 2020;44:467-76. [PMID: 31617643 DOI: 10.1002/cbin.11247] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Gunata M, Parlakpinar H. A review of myocardial ischaemia/reperfusion injury: Pathophysiology, experimental models, biomarkers, genetics and pharmacological treatment. Cell Biochem Funct 2021;39:190-217. [PMID: 32892450 DOI: 10.1002/cbf.3587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
6 Wang J, Wang L, Lou GH, Zeng HR, Hu J, Huang QW, Peng W, Yang XB. Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol 2019;57:193-225. [PMID: 30963783 DOI: 10.1080/13880209.2019.1577466] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 26.7] [Reference Citation Analysis]
7 Cai Y, Xin Q, Lu J, Miao Y, Lin Q, Cong W, Chen K. A New Therapeutic Candidate for Cardiovascular Diseases: Berberine. Front Pharmacol 2021;12:631100. [PMID: 33815112 DOI: 10.3389/fphar.2021.631100] [Reference Citation Analysis]